Company Ticker News January 6, 2022Provention Bio to Present at the Virtual H.C. Wainwright BioConnect Conference 0 0 Share
Company Ticker News November 26, 2021Wall Street Analysts Predict a 167% Upside in Provention Bio, Inc. (PRVB): Here's What You Should Know 0 0 Share
Press Release November 23, 2021Provention Bio Shares Gain On Teplizumab Regulatory Update For Type 1 Diabetes 0 0 Share
Press Release November 22, 2021Provention Bio Provides Regulatory Update for Teplizumab At-Risk Type 1 Diabetes Approval Pathway 0 0 Share
Company Ticker News November 10, 2021How Much Upside is Left in Provention Bio, Inc. (PRVB)? Wall Street Analysts Think 187% 0 0 Share
Company Ticker News November 10, 2021Provention Bio, Inc. (PRVB) Upgraded to Buy: What Does It Mean for the Stock? 0 0 Share
Press Release November 9, 2021Provention Bio Puts Type 1 Diabetes to the Test with Pledge Campaign for Diabetes Awareness Month 0 0 Share
Press Release November 6, 2021Provention Bio Appoints Miguel Sanjuan, Ph.D. as Senior Vice President of Research and Early Development 0 0 Share
